Latest Articles
Optimizing Therapy for MMR-Proficient Endometrial Cancer - OncLive
Optimizing Therapy for MMR-Proficient Endometrial Cancer OncLive
Published: July 31, 2025, 2:27 p.m.
Endometrial Cancer: Future Directions and Unmet Needs - OncLive
Endometrial Cancer: Future Directions and Unmet Needs OncLive
Published: July 31, 2025, 2:03 p.m.
Apollo Cancer Centres Launches ‘End-O Check’ – An Early Screening and Diagnosis Program for Endometrial and Ovarian Cancers - APN News
Apollo Cancer Centres Launches ‘End-O Check’ – An Early Screening and Diagnosis Program for Endometrial and Ovarian Cancers APN News
Published: July 31, 2025, 9:37 a.m.
Johor Specialist Hospital pioneers robotic sentinel node biopsy for endometrial cancer in the Southern region - Malaysiakini
Johor Specialist Hospital pioneers robotic sentinel node biopsy for endometrial cancer in the Southern region Malaysiakini
Published: July 31, 2025, 2:33 a.m.
Early screening is vital for beating endometrial, ovarian cancers: Experts - Ahmedabad Mirror
Early screening is vital for beating endometrial, ovarian cancers: Experts Ahmedabad Mirror
Published: July 31, 2025, 1:18 a.m.
First Early Endometrial Cancer Detection Test Launched By Gnosis - Inside Precision Medicine
First Early Endometrial Cancer Detection Test Launched By Gnosis Inside Precision Medicine
Published: July 30, 2025, 6:06 p.m.
First Early Endometrial Cancer Detection Test Launched by Gnosis - Inside Precision Medicine
First Early Endometrial Cancer Detection Test Launched by Gnosis Inside Precision Medicine
Published: July 30, 2025, 6:06 p.m.
Early detection prog for endometrial, ovarian cancer in women launched - The Times of India
Early detection prog for endometrial, ovarian cancer in women launched The Times of India
Published: July 30, 2025, 5:37 p.m.
Early detection prog for endometrial, ovarian cancer in women launched - Times of India
Early detection prog for endometrial, ovarian cancer in women launched Times of India
Published: July 30, 2025, 5:37 p.m.
Gnosis Launches EdenDx, the First Non-Invasive Liquid-Based Cytology U.S. Test for Early Endometrial Cancer Detection - PR Newswire
Gnosis Launches EdenDx, the First Non-Invasive Liquid-Based Cytology U.S. Test for Early Endometrial Cancer Detection PR Newswire
Published: July 30, 2025, 3:04 p.m.
Link copied to clipboard!